// App-Quantinova.ai

1464 : Outcome of Pediatric-Type Therapy for Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA): A Study by the Japan Adult Leukemia Study Group (JALSG ALL202-U study)

Researchers

Presenter

  • Fumihiko Hayakawa

Principal Investigators

  • Toshiaki Yujiri

  • Tomoki Naoe

  • Yasutaka Aoyama

  • Eisei Kondo

  • Katsumichi Fujimaki

  • Yasunori Ueda

  • Shigeki Ohtake

  • Yasushi Miyazaki

  • Shuichi Miyawaki

  • Kazunori Ohnishi

Medical Centers

  • Third Department of Internal Medicine, Yamagata University, Yamagata, Japan

  • Department of Haematology/Oncology, Kurashiki Central Hospital, Kurashiki City, Okayama, Japan

  • Department of Pathologic Oncology, Mie University Graduate School of Medicine, Mie, Japan

  • Department of Hematology, Seichokai Fuchu Hospital, Izumi, Japan

  • Saiseikai Maebashi Hospital, Gunma, Japan

  • Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

  • Clinical Laboratory Science, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan

  • Hematology/Oncology Division, Okayama University Graduate School, Okayama, Japan

  • Department of Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  • School of Medicine Oncology Center, Hamamatsu University School of Medicine, Hamamatsu, Japan

Locations

  • Japan

Companies

  • Fujisawa

  • Otsuka Pharmaceutica

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Pancreatitis

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

  • Carboxypeptidase M

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved